Industry Key Highlights
According to TechSci Research report, “India Analytics Market - By Region, Competition Forecast and Opportunities, 2029”, India analytics market is growing at a healthy CAGR rate of approximately 33.5% in the forecast period 2025-2029. The India analytics market is experiencing rapid expansion, driven by the increasing adoption of data-driven decision-making across various industries. Businesses, government agencies, and startups alike are leveraging analytics tools to enhance operational efficiency, optimize customer experiences, and gain competitive advantages.
Request For Sample Copy of Report For More Detailed Market insight: https://www.techsciresearch.com/sample-report.aspx?cid=15636#requestform
The key highlights of the market include:
With an expanding digital ecosystem, businesses are continuously seeking innovative ways to extract insights from data, leading to increasing demand for advanced analytics solutions in India.
Browse over XX market data Figures spread through XX Pages and an in-depth TOC on the "India Analytics Market.@https://www.techsciresearch.com/report/india-analytics-market/15636.html
Market Segmentation
The India analytics market is segmented based on component, verticals, type, organization size, and region.
By Component
By Verticals
By Type
By Organization Size
By Region
Emerging Trends in the India Analytics Market
1. Artificial Intelligence and Machine Learning Integration
The integration of AI and ML in analytics is transforming businesses by enabling predictive analytics, automated decision-making, and real-time insights. AI-powered analytics tools are helping companies process vast datasets efficiently and generate actionable insights.
2. Growth of Cloud-Based Analytics
Cloud computing is revolutionizing the analytics market by offering scalable and cost-effective solutions. Businesses are shifting towards cloud-based analytics platforms to enhance accessibility, reduce infrastructure costs, and enable real-time data processing.
3. Expansion of Real-Time Analytics
Real-time analytics is becoming increasingly popular across industries, particularly in e-commerce, BFSI, and healthcare. Companies are utilizing live data processing to optimize customer interactions, detect fraud, and improve supply chain management.
4. Data Privacy and Security Concerns
As analytics adoption increases, so do concerns over data privacy and security. Businesses are investing in advanced cybersecurity measures to ensure compliance with data protection regulations and prevent breaches.
5. Rise of Self-Service Analytics
With the growing demand for data-driven decision-making, self-service analytics tools are gaining traction. These platforms allow non-technical users to analyze data and generate reports without requiring extensive IT support.
6. Edge Analytics for IoT and Smart Devices
The rise of the Internet of Things (IoT) has led to the adoption of edge analytics, where data is processed closer to its source rather than relying on centralized cloud infrastructure. This trend is particularly relevant in industries such as manufacturing, healthcare, and retail.
7. Advanced Customer Experience Analytics
Companies are leveraging analytics to understand consumer behavior, personalize marketing efforts, and enhance customer experiences. Businesses in e-commerce and BFSI are particularly focused on customer data analytics to boost engagement and retention.
Key Market Drivers
1. Increasing Digital Transformation Initiatives
India’s growing digital economy is driving the demand for analytics solutions. Organizations across sectors are embracing data-driven strategies to gain a competitive edge.
2. Growing Adoption of Big Data and Business Intelligence
Enterprises are investing in big data and business intelligence solutions to optimize operations, improve decision-making, and unlock new business opportunities.
3. Government Support and Regulatory Policies
Initiatives such as "Digital India" and the promotion of AI and data analytics by the government are encouraging businesses to invest in analytics capabilities.
4. Rising Demand for Fraud Detection and Risk Management
The BFSI sector is utilizing analytics for fraud prevention, credit risk assessment, and regulatory compliance, further driving market growth.
5. Expansion of E-Commerce and Omnichannel Retailing
With the surge in online shopping, retailers are using analytics to enhance customer insights, personalize offerings, and optimize inventory management.
6. Growth of Smart Cities and IoT Adoption
Smart city projects and IoT adoption in India are fueling the need for real-time analytics in traffic management, energy efficiency, and public safety.
Competitive Analysis
The India analytics market is highly competitive, with both domestic and international players vying for market share. Some of the key players include:
1. Tata Consultancy Services (TCS)
TCS offers a comprehensive range of analytics services, including business intelligence, AI-driven analytics, and cloud-based solutions.
2. Wipro Limited
Wipro provides advanced analytics and AI-driven insights across various industries, with a strong focus on BFSI and healthcare.
3. Infosys Technologies
Infosys delivers analytics solutions focusing on automation, predictive modeling, and data visualization.
4. Accenture India
Accenture specializes in data-driven digital transformation, offering end-to-end analytics solutions.
5. IBM India
IBM provides AI-powered analytics and business intelligence tools, catering to enterprises across multiple sectors.
6. Microsoft India
Microsoft offers cloud-based analytics solutions through its Azure platform, enabling businesses to leverage data for strategic decision-making.
7. Mu Sigma
A leading data analytics firm, Mu Sigma focuses on big data analytics, AI-driven solutions, and customer experience optimization.
The market is witnessing increasing competition, with companies focusing on innovation, partnerships, and acquisitions to strengthen their analytics offerings.
Future Outlook
The India analytics market is poised for substantial growth, driven by digital transformation initiatives, increasing AI adoption, and the expanding role of data analytics across industries. Over the next five years, we can expect:
As businesses continue to recognize the value of data-driven insights, the India analytics market will play a pivotal role in shaping the country's digital future.
Customers can also request for 10% free customization on this report.
10 Benefits of the Research Report
Conclusion
The India analytics market is undergoing a transformative phase, with increasing adoption across industries driven by AI, big data, and cloud computing. As businesses recognize the value of data-driven decision-making, the demand for advanced analytics solutions will continue to rise. With strong government support, a thriving startup ecosystem, and an expanding digital economy, India is set to become a global hub for analytics innovation. Companies that leverage analytics effectively will gain a significant competitive advantage in this rapidly evolving market.
Contact US:
Techsci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +13322586602
Email: sales@techsciresearch.com
Web: https://www.techsciresearch.com/
Non-Small Cell Lung Cancer Market is Expected to Increase With a CAGR of 10.7% for the Study Period of 2017-2030: DelveInsight (Albany, US) DelveInsight has introduced a new Market Insights, Epidemiology, and Market Forecast Report on "Non-Small Cell Lung Cancer Market Insights, Epidemiology, and Market Forecast-2030" to its portfolio.Key Highlights from report are:As per the DelveInsight analysis, the total incident cases of NSCLC in the 7MM were observed to be 484,726 cases in the year 2017.
These cases are expected to grow with a significant CAGR in the study period 2017–2030.There are different types of treatment available for NSCLC; however, mainly 10 types of standard treatment are used, which include Surgery, Radiation therapy, Chemotherapy, Targeted therapy, Immunotherapy, Laser therapy, Photodynamic therapy (PDT), Cryosurgery, Electrocautery, and Watchful waiting.The market size of NSCLC in the 7MM is expected to increase during study period.
According to the estimates, the highest contribution in the market size of NSCLC is from the United States followed by Japan, Germany, and the UK.One of the most exciting developments in lung cancer medicine is the introduction of targeted treatments.Request for free sample pages to know more on Non-Small Cell Lung Cancer Market Forecast NSCLC is the most common type of lung cancer accounted for approximately 85% of all lung cancers.
The disease epidemiology included in the report provides historical as well as forecasted Non-Small Cell Lung Cancer epidemiology, which is segmented as Total Incident cases of NSCLC patients, Total Incident cases of NSCLC patients by Histology, Total Diagnosed cases of NSCLC patients by Stages, Total NSCLC cases of patients by Genetic mutation/Biomarkers, and Total Treated Cases of NSCLC patients by Line of Therapies scenario of NSCLC in the 7MM.The total NSCLC incident cases in the 7MM were observed to be 484,726 cases in 2017.Click here to know more on Non-Small Cell Lung Cancer pipelineNSCLC report encloses the detailed analysis of Non-Small Cell Lung Cancer marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs.
The therapies that are approved for the NSCLC treatment are Rozlytrek (Entrectinib), Imfinzi (Durvalumab), Opdivo (Nivolumab), Tecentriq (Atezolizumab), Keytruda (Pembrolizumab), Tafinlar (Dabrafenib) in combination with Mekinist (Trametinib), Tagrisso (osimertinib), Lorbrena/Lorviqua (Lorlatinib), Vizimpro (Dacomitinib), Alunbrig (Brigatinib), Alecensa (Alectinib), Vitrakvi (Larotrectinib), Portrazza (Necitumumab) along with many more.Drugs covered in the report are:-There are several key players robustly involved in developing potential products such asNazartinib (EGF816)Capmatinib (INC280)Tepmetko (tepotinib)MerestinibJNJ-61186372 (JNJ-6372)Vemurafenib Plus CobimetinibX-396 (Ensartinib)Tedopi (OSE2101)Selpercatinib (LY3527723/ LOXO-292)SAR408701Braftovi (encorafinib) + Mektovi (binimetinib)PADCEV (enfortumab vedotin/ASG-22ME)Pralsetinib (BLU-667)TAK-788: Canakinumab (ACZ885)Avelumab (Bavencio)Veliparib (ABT-888): Sitravatinib (MGCD516)TesevatinibRomiplostim: CabozantinibSym015AMG 510INCMGA00012 (MGA012)Libtayo (Cemiplimab)BavituximabM7824 (Bintrafusp alfa)And many others Key Players covered in the report are:-Novartis PharmaceuticalsMerck KGaAEli Lilly and CompanyJanssen Research & DevelopmentHoffmann-La RocheXcoveryBeyondSpring PharmaceuticalsOSE ImmunotherapeuticsSanofiPfizerAstellas PharmaSeattle GeneticsBlueprint Medicines CorporationTakedaAbbVieKadmon CorporationAmgenSymphogenRegeneron PharmaceuticalsPeregrine PharmaceuticalsAvid BioservicesGlaxoSmithKlineAnd many othersThe report includes provides in depth analysis historical and forecasted Market Share (%) Distribution of NSCLC, Market Share (%) Distribution of NSCLC by Mutations/Biomarkers, Total Market Size of PD-L1 NSCLC, Total Market Size of BRAF NSCLC, Total Market Size of c-Met, Total Market Size of EGFR, Total Market Size of ALK as well.The reasons for buying this report:The report proffers an overview of pathophysiology, various diagnostic approaches and NSCLC treatment algorithm, including detailed chapters for marketed products and emerging therapies.Historical and forecasted Non-Small Cell Lung Cancer epidemiology in 7MM covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2017-2030.Detailed historical and forecasted NSCLC market covering the United States, EU5 and Japan from 2017-2030.
Pipeline analysis across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with comprehensive clinical profiles, key cross-competition, launch date along with product development activities.
